4//SEC Filing
Hayden Michael R 4
Accession 0000874015-25-000157
CIK 0000874015other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:54 PM ET
Size
8.4 KB
Accession
0000874015-25-000157
Insider Transaction Report
Form 4
Hayden Michael R
Director
Transactions
- Exercise/Conversion
Common Stock
2025-07-15+4,079→ 54,298 total - Exercise/Conversion
Restricted Stock Unit
2025-07-15−4,079→ 9,897 totalExercise: $0.00→ Common Stock (4,079 underlying)
Holdings
- 2,000(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- [F2]These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F4]Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001352908
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:54 PM ET
- Size
- 8.4 KB